Sagimet Biosciences (SGMT) Gains from Investment Securities: 2023-2024
Historic Gains from Investment Securities for Sagimet Biosciences (SGMT) over the last 1 years, with Jun 2024 value amounting to $49,000.
- Sagimet Biosciences' Gains from Investment Securities rose 5000.00% to $49,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $150,000, marking a year-over-year change of. This contributed to the annual value of $149,000 for FY2024, which is 96.03% down from last year.
- Latest data reveals that Sagimet Biosciences reported Gains from Investment Securities of $49,000 as of Q2 2024, which was down 98.61% from $3.5 million recorded in Q1 2024.
- In the past 5 years, Sagimet Biosciences' Gains from Investment Securities registered a high of $3.5 million during Q1 2024, and its lowest value of -$1,000 during Q2 2023.
- Over the past 2 years, Sagimet Biosciences' median Gains from Investment Securities value was $49,000 (recorded in 2024), while the average stood at $733,761.
- Data for Sagimet Biosciences' Gains from Investment Securities shows a peak YoY skyrocketed of 175,840.15% (in 2024) over the last 5 years.
- Sagimet Biosciences' Gains from Investment Securities (Quarterly) stood at $100,000 in 2023, then skyrocketed by 5,000.00% to $49,000 in 2024.
- Its Gains from Investment Securities was $49,000 in Q2 2024, compared to $3.5 million in Q1 2024 and $100,000 in Q3 2023.